跳至主要内容
临床试验/NCT05870514
NCT05870514招募中2 期

Efficacy and Safety of Fospropofol Disodium Versus Propofol for Deep Sedation in Critically Ill Patients

Xiaobo Yang, MD1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2023年6月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
60
试验地点
1
主要终点
The percentage of time in the target sedation range without rescue sedation

研究概览

简要总结

The purpose of this study is to evaluate the efficacy and safety of fospropofol disodium for injection compared to propofol for deep sedation in mechanically ventilated ICU patients.

详细描述

This is a randomized, open-label, small sample study using fospropofol disodium and propofol for deep sedation in mechanically ventilated ICU patients. Subjects are randomized to different treatment groups (including 1 for fospropofol disodium and 1 for propofol). Remifentanil is co-administered with fospropofol or propofol. Efficacy and safety profiles of fospropofol disodium and propofol are to be monitoted.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥ 18 and ≤ 80 years; Expected to require deep sedation ≥8 hours; Requirement for deep sedation (a Narcotrend index between 13 and 64).

排除标准

  • Body mass index (BMI) <18 or >30 kg/m2; Contraindicate or allergic to study drugs; Moribund state; Expected to have a general anesthesia within 8 hours; Myasthenia gravis; Acute hepatitis or serious hepatic dysfunction (Child-Pugh class C); Chronic kidney disease with glomerular filtration rate (GFR) < 29 ml/min/1.73m2; Systolic blood pressure less than 90 mm Hg after appropriate intravenous volume replacement and continuous infusions of 2 vasopressors; Acute severe neurological disorder and any other condition interfering with RASS assessment; Pregnancy or lactation; Unstable angina; Acute myocardial infarction; Left ventricular ejection fraction less than 30%; Heart rate less than 50 beats/min; Second- or third-degree heart block in the absence of a pacemaker; Alcohol abuse or drug abuse.

研究组 & 干预措施

Fospropofol disodium for injection

Experimental

Patients in the experimental group received fospropofol disodium for injection at an initial infusion rate of 10 mg/kg/h and adjusted to maintain a Narcotrend index between 13 and 64.

干预措施: Fospropofol disodium for injection (Drug)

Propofol

Active Comparator

Patients in the active comparator group received propofol at an initial infusion rate of 3 mg/kg/h and adjusted to maintain a Narcotrend index between 13 and 64.

干预措施: Propofol (Drug)

结局指标

主要结局

The percentage of time in the target sedation range without rescue sedation

时间窗: From start of study to 48 hours

The percentage of time in the target sedation range without rescue sedation

次要结局

  • 7-day ventilator free time(From start of study to 7 days)
  • Length of ICU stay(From start of study to 28 days)
  • 28-day mortality(From start of study to 28 days)
  • Adverse events(From start of study to 48 hours)
  • Success rate of extubation within 7 days(From start of study to 7 days)

研究者

发起方
Xiaobo Yang, MD
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Xiaobo Yang, MD

Clinical Professor

Wuhan Union Hospital, China

研究点 (1)

Loading locations...

相似试验

Efficacy and Safety of Fospropofol Disodium Versus... | 临床试验